Prosecution Insights
Last updated: November 04, 2026
Application No. 18/541,071

IMPLANTABLE VASCULAR ACCESS PORT WITH DUAL, HIGH-FLOW TRANS-CHAMBER AND LOW-FLOW, ACCESS, AND NEEDLE LOCK FOR HIGH-FLOW

Non-Final OA §102
Filed
Dec 15, 2023
Priority
Mar 25, 2019 — provisional 62/823,103 +5 more
Examiner
HALL, DEANNA K
Art Unit
3783
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Onco Access Ltd.
OA Round
1 (Non-Final)
76%
Grant Probability
Favorable
1-2
OA Rounds
3m
Est. Remaining
91%
With Interview

Examiner Intelligence

Grants 76% — above average
76%
Career Allowance Rate
892 granted / 1178 resolved
+5.7% vs TC avg
Strong +15% interview lift
Without
With
+15.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
43 currently pending
Career history
1233
Total Applications
across all art units

Statute-Specific Performance

§101
1.3%
-38.7% vs TC avg
§103
49.6%
+9.6% vs TC avg
§102
32.1%
-7.9% vs TC avg
§112
11.4%
-28.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 1178 resolved cases

Office Action

§102
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Information Disclosure Statement The information disclosure statement (IDS) submitted on 6/26/24 is in compliance with the provisions of 37 CFR 1.97(b). Accordingly, the IDS is being considered by the Examiner. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim 1 is rejected under 35 U.S.C. 102(a)(1) as being anticipated by Zinn et al. (US 2007/0219510) (“Zinn”). Zinn discloses: An implantable vascular access port (see abstract, Fig. 8, [0031]), comprising: a port body 102 having a lower or floor wall 102b, an upper wall 102a substantially parallel thereto and at least one sidewall extending 108,170 between said upper wall and said lower or floor wall, said port body having at least one internal chamber 118, said port body having at least one outlet aperture 116a,b,162 formed in said at least one sidewall thereof in communication with said at least one internal chamber, said port body being formed opposite said at least one outlet aperture with at least one lateral access aperture 172 defining a straight-line- access path or direction to said at least one outlet aperture 162 through said at least one internal chamber, said main port body being formed in said upper wall with at least one top access aperture 136 defining a perpendicular- or vertical-access path or direction substantially perpendicular to said upper wall and said lower or floor wall; at least one first septum 174 attached to said port body and covering or closing said at least one lateral access aperture; at least one second septum 134 attached to said port body and covering or closing said at least one top access aperture, said at least one first septum and said at least one second septum being made of self- sealing penetrable material designed for repeated piercing by access needles [0004,0032]; and at least one hollow outlet tube attached to the main port body and in fluid communication with said at least one internal chamber and said at least one outlet aperture. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to DEANNA K HALL whose telephone number is (571)272-2819. The examiner can normally be reached M-F 8:30am- 4:30pm EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Kevin Sirmons can be reached at 571-272-4965. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /DEANNA K HALL/Primary Examiner, Art Unit 3783
Read full office action

Prosecution Timeline

Dec 15, 2023
Application Filed
Jul 15, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12779173
Multi-Function Adapter for Vascular Access Device Placement
2y 6m to grant Granted Nov 03, 2026
Patent 12773481
URINARY CATHETER KIT
3y 3m to grant Granted Oct 27, 2026
Patent 12765748
SYSTEMS AND METHODS FOR USE OF A VARIABLE STIFFNESS FLEXIBLE ELONGATE DEVICE
3y 5m to grant Granted Oct 20, 2026
Patent 12766251
FRONT-LOADABLE FLUID TRANSFER ASSEMBLIES AND RELATED MEDICAL FLUID TRANSFER SYSTEMS AND METHODS
3y 4m to grant Granted Oct 20, 2026
Patent 12766267
AUTOINJECTOR
2y 6m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
76%
Grant Probability
91%
With Interview (+15.3%)
3y 2m (~3m remaining)
Median Time to Grant
Low
PTA Risk
Based on 1178 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month